QuantRankUS equity stock ranking
← Back to ranking
#42Health Care· Health Care Technology

SOLVBuy

Solventum

$74.26USD
63
Composite Score62.9Strong
+47
Margin of safety+47%Undervalued
Fair value$139.82
Target$225.63
Loss chance22%

Price (1y)

Loading price history…

Fair price check

4 different valuation methods each estimate what SOLV should be worth, then we compare to today's price.

Looks undervalued
Models suggest SOLV is trading below fair value
Today's price
$74.26
Median fair price
$139.82
+88% vs today
Of 4 methods:2 say cheap1 say fair1 say pricey
  • EV/EBITDAUndervalued
    thinks it's a bargain — estimates $225.63, about 204% above today
  • P/E multiplesUndervalued
    thinks it's a bargain — estimates $196.21, about 164% above today
  • P/B multiplesFair
    thinks it's fairly priced — estimates $83.43, about 12% above today
  • DCF (2-stage)Overvalued
    thinks it's expensive — estimates $31.34, about 58% below today

How to read this: “Cheap” = method's fair price is at least 20% above today. “Fair” = within ±10–20%. “Pricey” = at least 10% below today. Outliers (values more than 5× or less than 0.2× today's price) are excluded.

Fair price ensemble

Median fair
$139.82
Margin of safety
+46.9%
Max (ex-outliers)
$225.63
Tangible BVPS
—
MethodValue
Graham (defensive)skipped
P/E multiples(vs sector peers)$196.21
P/B multiples(vs sector peers)$83.43
EV/EBITDA(vs sector peers)$225.63
Residual Incomeskipped
DCF (2-stage)$31.34
  • value trap risk

Median of all applicable methods (current price $74.26). Outliers above 5× or below 0.2× current price are excluded from the max but kept in the median. See methodology for the 6-method ensemble + 7 defenses.

Pillar breakdown

8 dimensions, each scored 0–100 against the universe

Health Care median (n=59)
  • Quality
    Profit margins & asset efficiency
    78
    Strong
  • Value
    Price vs fundamentals
    78
    Strong
  • Growth
    Revenue & earnings trajectory
    61
    Decent
  • Momentum
    Recent price strength
    31
    Weak
  • Health
    Balance sheet & solvency
    31
    Weak
  • Profitability
    ROE, ROA, ROIC
    64
    Decent
  • Technical
    Trend & volatility signals
    72
    Strong
  • Risk
    Volatility & drawdown profile
    43
    Weak
0305070100
Strong (70+)Decent (50–70)Weak (30–50)Poor (<30)

Pillars not shown: Sentiment, ML (Phase 5+).

Raw fundamentals (SEC EDGAR)

MetricValue
Market cap$12.86B
Revenue (TTM)$8.26B
Net income (TTM)$1.43B
Operating cash flow (TTM)$151.00M
CapEx (TTM)$354.00M
Free cash flow (TTM)CFO − CapEx$-203.00M
Total assets$14.10B
Total liabilities$9.13B
Stockholders' equity$4.97B
Cash & equivalents$561.00M
Shares outstanding173.17M
EPS (basic)$0.07
EPS (diluted)$0.07
P/E ratio (TTM)8.98

TTM = trailing twelve months. Balance sheet items are point-in-time (latest filing).

Data quality

Latest filed date
2026-05-05
Latest period end
2026-04-30
Filing lag
11 days
Missing metrics
3(cost_of_revenue, interest_expense, dividends_paid)

Phase 3c — composite is the 8-pillar weighted score over quality, value, growth, momentum, health, profitability, technical, and risk. Sentiment + ML pillars land in Phases 5-6; until then their weight redistributes pro-rata. Fair price is the median of 6 valuation methods (Graham, P/E / P/B / EV-EBITDA multiples, RIM, DCF) with outliers above 5× current price excluded from the max. Risk-overlay flags annotate only — they suppress the entered-top-5 badge but do not modify the composite.